SCHEMBL5475607

SCHEMBL5475607

CC(C)c1c(O)ccc2c1oc1ccc(C#N)cc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 1/20 0.34
▸ PIM1 P11309 1/20 0.33
▸ CSNK2A2 P19784 1/20 0.33
▸ CSNK2B P67870 1/20 0.33
▸ PIM3 Q86V86 1/20 0.33
▸ PIM2 Q9P1W9 1/20 0.33
▸ GUSB P08236 1/20 0.33
▸ AR P10275 2/20 0.33
▸ NOS3 P29474 1/20 0.33
▸ NOS1 P29475 1/20 0.33
▸ NOS2 P35228 1/20 0.33
▸ CYP2A6 P11509 1/20 0.33
▸ CYP2C9 P11712 1/20 0.32
▸ HSD17B3 P37058 1/20 0.32
▸ TRPV1 Q8NER1 1/20 0.32
▸ KDM4E B2RXH2 3/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5471761 0.87 GUSB (0.33) HRH4PIM1CSNK2A2CSNK2BPIM3
SCHEMBL5477181 0.82 PDE5A (0.38) HRH4GUSBAR
SCHEMBL13564574 0.79 CYP2A6 (0.44) HRH4PIM1CSNK2A2CSNK2BPIM3
SCHEMBL5477167 0.73 HRH4 (0.36) HRH4PIM1CSNK2A2CSNK2BPIM3
SCHEMBL5472664 0.73 PDE5A (0.36) GUSBARMEN1MAPTKMT2A
SCHEMBL548410 0.72 CYP2A6 (0.50) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL29149150 0.71 TNKS (0.50) CSNK2A2CSNK2BARCYP2C9KDM4E
SCHEMBL16905656 0.70 KDM4E (0.39) HRH4PIM1CSNK2A2CSNK2BPIM3
SCHEMBL11554110 0.69 CYP2A6 (0.44) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL5471196 0.69 KDM4E (0.60) CSNK2A2CSNK2BHSD17B3KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070093548-A1 Use of progesterone receptor modulators WYETH (US) 2007-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093548-A1 Use of progesterone receptor modulators PGR, GNRHR, PGRMC2 HRH4 1091/4885PIM1 4855/4885CSNK2A2 4136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback